Hyperion DeFi, Inc. (HYPD)
3.60
+0.21
(+6.19%)
USD |
NASDAQ |
Aug 27, 16:00
3.57
-0.03
(-0.83%)
After-Hours: 20:00
Hyperion DeFi Total Liabilities (Quarterly) : 11.20M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 11.20M |
| March 31, 2026 | 11.57M |
| December 31, 2025 | 10.70M |
| September 30, 2025 | 12.03M |
| June 30, 2025 | 18.30M |
| March 31, 2025 | 15.70M |
| December 31, 2024 | 16.76M |
| September 30, 2024 | 19.08M |
| June 30, 2024 | 21.36M |
| March 31, 2024 | 24.36M |
| December 31, 2023 | 19.78M |
| September 30, 2023 | 19.09M |
| June 30, 2023 | 18.82M |
| March 31, 2023 | 13.50M |
| December 31, 2022 | 13.80M |
| September 30, 2022 | 11.08M |
| June 30, 2022 | 12.00M |
| March 31, 2022 | 10.39M |
| December 31, 2021 | 11.19M |
| September 30, 2021 | 20.75M |
| Date | Value |
|---|---|
| June 30, 2021 | 21.59M |
| March 31, 2021 | 16.71M |
| December 31, 2020 | 18.60M |
| September 30, 2020 | 7.197M |
| June 30, 2020 | 3.108M |
| March 31, 2020 | 2.583M |
| December 31, 2019 | 2.957M |
| September 30, 2019 | 2.478M |
| June 30, 2019 | 2.418M |
| March 31, 2019 | 2.568M |
| December 31, 2018 | 3.140M |
| September 30, 2018 | 1.732M |
| June 30, 2018 | 1.280M |
| March 31, 2018 | 1.123M |
| December 31, 2017 | 0.5526M |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | 0.4237M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Omeros Corp. | 338.18M |
| Talphera, Inc. | 12.40M |
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 182.93M |
| Veru, Inc. | 8.651M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 113.14M |
| Shareholders Equity (Quarterly) | 101.93M |
| Debt to Equity Ratio | 0.0874 |
| Current Ratio | 2.343 |
| Net Debt Paydown Yield | 0.94% |